ZW7G.1=VOML[X5S.|EZAZ+>];!#
SYSTEM PROCESSING...
ZW7G.1=VOML[X5S.|EZAZ+>];!#
SYSTEM PROCESSING...
Posted: 2025-05-31 21:52:49 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-31 21:53:07 UTC
Verified By
Rollup News
Moderna's mRNA-based HIV vaccines faced setbacks as up to 18% of trial participants experienced skin reactions. These experimental vaccines aim to enhance the immune system's fight against HIV, but long-term effects remain unknown. Meanwhile, PrEP is a cheap, tested, and available option that cuts HIV transmission by over 99% when taken correctly.
mRNA HIV vaccines face challenges with skin reactions in trials
PrEP remains a reliable and effective option for HIV prevention
Experimental vaccines have unknown long-term effects
Skin reactions in trial participants
Unknown long-term effects of mRNA vaccines
Experimental nature of the vaccines